This is consistent with the findings in this study that found no correlation between RANTES levels and either combined CVD or CAD alone, which indicate that plasma RANTES levels may not be a suitable biomarker for assessing CVD risk in humans. The gene discussed is CCL5; the disease is coronary artery disorder.